Treasurer, Kelly Barnhill, MBA, CN, CCN
Johnson Center for Child Health & Development
Ms. Barnhill also serves on ARI’s Scientific Advisory Panel
Kelly Barnhill is Clinical Care Director at The Johnson Center for Child Health and Development, overseeing management and implementation of multidisciplinary care across the practices within the organization. She is a Certified Clinical Nutritionist, with over a decade of experience working with nutrition in children with autism and related disorders. At the Johnson Center she directs a team of dieticians and nutritionists that has served more than 3,000 children through this practice. Learn more about Kelly Barnhill.
Robert Hendren, D.O.
University of California, San Francisco Medical Center
Dr. Hendren also serves on ARI’s Scientific Advisory Panel
Dr. Robert L. Hendren, director of Child and Adolescent Psychiatry, treats patients at the UCSF Autism Clinic. In addition to autism, he specializes in the diagnosis and treatment of neurodevelopmental disorders such as pervasive developmental, bipolar, schizophrenia spectrum and impulse control disorders. In his research, he studies pharmacology and nutrition in treating autism, and the biological effects of nutritional supplementation including vitamin B12, vitamin D, Omega-3 fatty acids. Learn more about Dr. Hendren
Secretary, S. Jill James, Ph.D.
University of Arkansas for Medical Sciences
Dr. James also serves on ARI’s Scientific Advisory Panel
Dr. James is a Research Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences and the Director of the Autism Metabolic Genomics Laboratory at the Arkansas Children’s Hospital Research Institute. She received her undergraduate degree from Mills College in Oakland, CA and her doctorate in Nutritional Biochemistry from UCLA. Dr. James has more than 25 years of research experience and is nationally and internationally recognized as an expert in on folate and glutathione metabolism. Her research has been funded by NIH and the Department of Defense and is focused on metabolic, genetic, and epigenetic abnormalities in children with autism and their mothers. Learn more about Dr. James.
Paul Meeks, CFA, MBA
Independent Solutions Wealth Management
Paul Meeks has covered the technology industry as an analyst or manager on Wall Street since 1992. He is a 30-year chief investment officer, portfolio manager, and private and public equity analyst investing in technology, growth, and sustainable companies. From 2007 to 2012, Meeks was a portfolio manager and managing director at Merrill Lynch Investment Managers, where he started and managed six portfolios totaling $7 billion. He is an adjunct professor of finance at the College of Charleston and The Citadel.
Chairman, Marvin Natowicz, M.D., Ph.D.
Case Western Reserve University School of Medicine
Dr. Natowicz also serves on ARI’s Scientific Advisory Panel
Dr. Natowicz is a medical geneticist and clinical pathologist at the Cleveland Clinic and Professor of Pathology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. His clinical practice involves the evaluation and care of persons with neurogenetic and neurometabolic conditions, and he has a special interest in working with persons having autism and other developmental disabilities. His research interests include genetic and metabolic aspects of autism, the clinical chemistry of genetic metabolic disorders, and ethical and public policy issues in genetic medicine. Learn more about Dr. Natowicz
Kenneth Sassower, M.D.
Massachusetts General Hospital
Harvard Medical School
Dr. Sassower also serves on ARI’s Scientific Advisory Panel
Dr. Kenneth Sassower is a neurologist in Boston, Massachusetts and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He attended and graduated from medical school in 1982, having over 36 years of diverse experience, especially in Neurology. Dr. Sassower also serves as Instructor in Neurology, Harvard Medical School and Assistant in Neurology, Massachusetts General Hospital, Boston. Learn more about Dr. Sassower.
Chief Operating Officer at Adams Street Partners
James Walker has more than 30 years of senior executive leadership experience in the wealth management and asset management industries. Before joining Adams Street, he was COO at Credit Suisse Private Bank Americas, spent seven years at Morgan Stanley Global Wealth Management (and predecessor firms), served as COO – Investment Advisory Services at Citi Global Wealth Management, and then as Director of Strategy, Finance and Risk. He began his career at Merrill Lynch, rising to Chief Administrative Officer for the Global Private Client business. Mr. Walker has served on multiple boards and is a regular lecturer at MIT’s Sloan School of Business.
Harland Winter, M.D.
Massachusetts General Hospital
Harvard Medical School
Dr. Winter also serves on ARI’s Scientific Advisory Panel
Dr. Harland Winter, M.D., is a pediatric gastroenterologist in Boston, Massachusetts. He is affiliated with Massachusetts General Hospital, Boston Children’s Hospital, and Newton-Wellesley Hospital. Dr. Winter is the Director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Massachusetts General Hospital and an Associate Professor of Pediatrics at Harvard Medical School. He is an internationally regarded physician and accomplished researcher and professor having authored numerous published research and books on subjects related to IBD. Learn more about Dr. Winter.